Dionysis Nikolopoulos (@dionysisnik) 's Twitter Profile
Dionysis Nikolopoulos

@dionysisnik

Researcher at Karolinska Institutet

ID: 1664265697978093569

calendar_today01-06-2023 13:40:46

21 Tweet

75 Followers

366 Following

Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

🦠Clinical case about #infections 👉39-year-old👩with #SLE and #APS 💊previous #CTX, current #HCQ & #methylprednisolone 16 mg/day 🤒episodes of persistent #fever ⏭️recurrent non-tuberculous mycobacterial infections 💡What's your clue about the cause? 📢RT this challenge!

Alvaro Gomez (@gomezg_alvaro) 's Twitter Profile Photo

Journal Impact Factor (JCR 2023, Web of Science) of top journals in #Rheumatology. Gentle reminder: JIF shall not be used to assess the quality of individual publications💡 #RheumTwitter

Journal Impact Factor (JCR 2023, Web of Science) of top journals in #Rheumatology.

Gentle reminder: JIF shall not be used to assess the quality of individual publications💡 #RheumTwitter
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Lupus Hub (@lupus_hub) 's Twitter Profile Photo

CONGRESS #ACR23 | Dionysis Nikolopoulos, Karolinska Institutet, discussed impact of neuropsychiatric #SLE on HRQoL in 2968 pts with SLE from 4 ph-III trials (BLISS-52, BLISS-76, BLISS-SC & EMBRACE). Pts with NPSLE had significantly lower SF-36 PCS (35.7 vs 39.6) & MCS scores (37.3 vs 41.4),

CONGRESS #ACR23 | <a href="/DionysisNik/">Dionysis Nikolopoulos</a>, <a href="/karolinskainst/">Karolinska Institutet</a>, discussed impact of neuropsychiatric #SLE on HRQoL in 2968 pts with SLE from 4 ph-III trials (BLISS-52, BLISS-76, BLISS-SC &amp; EMBRACE). Pts with NPSLE had significantly lower SF-36 PCS (35.7 vs 39.6) &amp; MCS scores (37.3 vs 41.4),
Areti Athanasiou (@aretiathanasiu) 's Twitter Profile Photo

«Με πήραν κάποιοι γονείς τηλέφωνο οι οποίοι ξέρετε δεν είναι από τους γονείς οι οποίοι για τους δικούς τους λόγους θέλουν να έχουν βήμα, προβολή...». Μιλάμε για άνιωθο τομάρι. Φτου σου ξεφτίλα. #τεμπη_εγκλημα

Dionysis Nikolopoulos (@dionysisnik) 's Twitter Profile Photo

🚩SLE-APS is associated with a less profound IFN-signature within the SLE population 🚩Distinct transcriptomic profiles characterise venous and arterial thrombotic events in SLE-APS. ard.bmj.com/content/early/…

🚩SLE-APS is associated with a less profound IFN-signature within the SLE population 
🚩Distinct transcriptomic profiles characterise venous and arterial thrombotic events in SLE-APS. 

ard.bmj.com/content/early/…
Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

Disentangling the riddle of #SLE with #APS Blood transcriptome analysis reveals a less pronounced IFN-signature and distinct molecular profiles in venous versus arterial events 🔬 Whole-blood RNA-sequencing ⭐ 299 SLE (108 SLE-aPL+) ⭐72 matched HC 👉 bit.ly/3PWPgCb

Disentangling the riddle of #SLE with #APS 

Blood transcriptome analysis reveals a less pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

🔬 Whole-blood RNA-sequencing
⭐ 299 SLE (108 SLE-aPL+)
⭐72 matched HC

👉 bit.ly/3PWPgCb
Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

Wha is the role of monocyte heterogeneity in #lupus? ▶️ subset-specific epigenetic and transcriptomic programmes identified ▶️ association with disease activity ▶️ lupus-specific subsets with distinctive functions revealed (complement and IFN related) 🔗 bit.ly/4d6NPuW

Wha is the role of monocyte heterogeneity in #lupus?

▶️ subset-specific epigenetic and transcriptomic programmes identified
▶️ association with disease activity
▶️ lupus-specific subsets with distinctive functions revealed (complement and IFN related)

🔗 bit.ly/4d6NPuW
Laura Andreoli (@lauraandreoli80) 's Twitter Profile Photo

🇮🇹The first paper of the Italian Registry of #pregnancy in #rheumaticdiseases is out!🤰 Cannot express enough gratitude & pride to 🙏outstanding investigators collecting data since 2018 🙏SIR - Società Italiana di Reumatologia for the support 🙏>1000 patients for participating rmdopen.bmj.com/content/10/2/e…

🇮🇹The first paper of the Italian Registry of #pregnancy in #rheumaticdiseases is out!🤰
Cannot express enough gratitude &amp; pride to
🙏outstanding investigators collecting data since 2018
🙏<a href="/SIRreumatologia/">SIR - Società Italiana di Reumatologia</a> for the support
🙏&gt;1000 patients for participating
rmdopen.bmj.com/content/10/2/e…
Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

🆕 What's the role of #stromalcells in the #pathogenesis of #GCA?🔥 🔴 Inflammatory events activate ineffective #repair mechanisms 🔲 Dysfunctional #smoothmusclecells & #fibroblasts phenotypically shift along their lineage and colonise the #intima 🔗 bit.ly/49X3OZP

🆕 What's the role of #stromalcells in the #pathogenesis of #GCA?🔥 

🔴 Inflammatory events activate ineffective #repair mechanisms
🔲 Dysfunctional #smoothmusclecells &amp; #fibroblasts phenotypically shift along their lineage and colonise the #intima

🔗  bit.ly/49X3OZP
Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

🎯 A novel #biomarker for #SystemicSclerosis: anti-protein arginine methyltransferase 5 (PRMT5) antibody 👫 prediction of #skin & #lung involvement. 🐁 immunisation with recombinant protein PRMT5 induced SSc-like manifestations 🔗 bit.ly/3Qrnnmm

🎯 A novel #biomarker for #SystemicSclerosis: anti-protein arginine methyltransferase 5 (PRMT5) antibody

👫  prediction of #skin &amp; #lung involvement.
🐁  immunisation with recombinant protein PRMT5 induced SSc-like manifestations

🔗  bit.ly/3Qrnnmm
David Liew (@drdavidliew) 's Twitter Profile Photo

Post-PEXIVAS, still controversy about plasma exchange in ANCA-assoc vasculitis. Guidelines recommend against routine use, no clear benefit in subgroup analysis, KenWarringtonMD tells #ARANZRA24 that Mayo Clinic have moved away from it. Many good people still use it, though, so…

Post-PEXIVAS, still controversy about plasma exchange in ANCA-assoc vasculitis. 

Guidelines recommend against routine use, no clear benefit in subgroup analysis, <a href="/MdWarrington/">KenWarringtonMD</a> tells #ARANZRA24 that <a href="/MayoClinic/">Mayo Clinic</a> have moved away from it. Many good people still use it, though, so…
EMEUNET (@emeunet) 's Twitter Profile Photo

Congratulations to all winners of the #EMEUNETtop10abstracts at #EULAR2024! Yvonne Tan Dionysis Nikolopoulos Quirine Dumoulin Jack Arnold Tsuneyasu Yoshida🇯🇵→🇺🇸 @m_scherlinger Celina Geiss Shinji Izuka Liubov Petelytska and Blaž Burja Keep following our #EMEUNET socials for updates on each abstract!

Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

🦋 Novel insights into the sex bias in #SLE ♀️ ♂️ X chromosome inactivation (XCI) may contribute to female prevalence 📉 XCI-skew is reduced in SLE compared with HC BUT 📈 XCI patterns of immune cells seem to be modulated by disease activity 🔗 bit.ly/3xrO0Bn

🦋 Novel insights into the sex bias in #SLE ♀️ ♂️ 

X chromosome inactivation (XCI) may contribute to female prevalence

📉 XCI-skew is reduced in SLE compared with HC
BUT 
📈 XCI patterns of immune cells seem to be modulated by disease activity

🔗  bit.ly/3xrO0Bn
Ioannis Parodis (@ioannisparodis) 's Twitter Profile Photo

#Interferon and #B-cell Signatures Inform #PrecisionMedicine in #Lupus Nephritis 💡Druggable pathways by #lupusnephritis transcriptome 💡Drugs benefit differentially depending on disease phase More: pubmed.ncbi.nlm.nih.gov/38899167/ KIReports By Dionysis Nikolopoulos @JuliusLindblom 3TR-IMI

#Interferon and #B-cell Signatures Inform #PrecisionMedicine in #Lupus Nephritis

💡Druggable pathways by #lupusnephritis transcriptome

💡Drugs benefit differentially depending on disease phase

More:
pubmed.ncbi.nlm.nih.gov/38899167/

<a href="/KIReports/">KIReports</a>

By <a href="/DionysisNik/">Dionysis Nikolopoulos</a> @JuliusLindblom <a href="/3TR_IMI/">3TR-IMI</a>
Nikos Sarantakos (@nikosarantakos) 's Twitter Profile Photo

Αστυνομικός βρίζει χυδαία τον ευρωβουλευτή Παππά (όργιο, κερατά, ψωλαρπάχτρα), ο Παππάς απαντάει πολύ πιο ήπια, και η ΝΔ ζητά να διαγραφεί ο Παππάς επειδή έβρισε ΤΟΥΣ αστυνομικούς (γκεμπελική διαστρέβλωση) Δεν είναι πειθαρχικό παράπτωμα αυτό του αστυνομικού;

Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

In the Sept issue ▶️ #APS #SLE by #transcriptomeanalysis 🦋 ❇️ #IFN I-II signature ▶️ highest in SLE-aPL-negative 🔵 Venous ▶️ neutrophils & B cells 🔴 Arterial ▶️ DNA-damage-response & impaired metabolism 🔗 bit.ly/4goyd7R Dionysis Nikolopoulos George Bertsias Ioannis Parodis

In the Sept issue ▶️ #APS #SLE by #transcriptomeanalysis 🦋
❇️ #IFN I-II signature ▶️ highest in SLE-aPL-negative
🔵 Venous ▶️ neutrophils &amp; B cells
🔴 Arterial ▶️ DNA-damage-response &amp; impaired metabolism
🔗  bit.ly/4goyd7R
<a href="/DionysisNik/">Dionysis Nikolopoulos</a> <a href="/george_bertsias/">George Bertsias</a> <a href="/IoannisParodis/">Ioannis Parodis</a>
3TR-IMI (@3tr_imi) 's Twitter Profile Photo

Day 1 of the #3TR Annual Meeting is done! ✅ What a fantastic start with insightful presentations, progress updates and breakout sessions! 🙌 We’d also like to thank our host AstraZeneca for making this meeting possible! See you tomorrow for Day 2! #3TR #Gothenburg

Day 1 of the #3TR Annual Meeting is done! ✅

What a fantastic start with insightful presentations, progress updates and breakout sessions! 🙌

We’d also like to thank our host <a href="/AstraZeneca/">AstraZeneca</a> for making this meeting possible!

See you tomorrow for Day 2!

#3TR #Gothenburg
Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

Molecular basis for the disease-modifying effects of #belimumab in #lupus: ✅ neutrophil degranulation, type I interferon signalling and cytokine production👉 good response ❌cell cycle checkpoints, PI3K/Akt and TGF-beta signalling pathways👉bad response ard.bmj.com/content/early/…

Molecular basis for the disease-modifying effects of #belimumab in #lupus:
✅ neutrophil degranulation, type I interferon signalling and cytokine production👉  good response
❌cell cycle checkpoints, PI3K/Akt and TGF-beta signalling pathways👉bad response
ard.bmj.com/content/early/…